CAS 79233-15-1: Deoxyandrographolide

Deoxyandrographolide enhances NGF-driven neurite growth and reduces TNF-α, IL-6 levels.

Deoxyandrographolide promotes glucose uptake through glucose transporter-4 translocation to plasma membrane in L6 myotubes and exerts antihyperglycemic effect in vivo.

Deoxyandrographolide

Deoxyandrographolide is a diterpenoid compound, which is a phytochemical extracted from the plant Andrographis paniculata. With its biosource rooted in traditional Asian medicine, this plant has garnered attention for its bioactive constituents. Deoxyandrographolide acts through modulating various molecular pathways, such as inhibiting pro-inflammatory cytokine production and oxidative stress, which contributes to its potential therapeutic roles. The compound finds its uses primarily in research focused on understanding its anti-inflammatory and potential immunomodulatory properties. Additionally, studies are exploring its efficacy in the context of metabolic disorders and as an adjunct in cancer research. These investigations aim to elucidate the compound's precise molecular interactions and possible beneficial effects on health, thus contributing to a deeper understanding of its pharmacological profile.